RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibril
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention | Journal of the American College of Cardiology
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
RE-DUAL PCI™ vs PIONEER AF-PCI™
Atrial Fibrillation and PCI - ppt download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…
AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups | tctmd.com
Objectives, The Site, Finance, and Role of The Ethics Committee, Sponsor and Research Organization
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
RE-DUAL PCI™ vs PIONEER AF-PCI™
AF and PCI in Practice. - ppt download
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial - The Lancet
AF and PCI in Practice. - ppt download
Atrial Fibrillation and PCI - ppt download
Antithrombotic strategies in elderly patients with acute coronary syndrome - ScienceDirect
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…
Subgroup Analysis from the RE-DUAL PCI Trial | tctmd.com
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt download
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions
Atrial Fibrillation and PCI - ppt download
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status - tctmd.com
Direct-acting Anticoagulants in Chronic Coronary Syndromes | ECR Journal
Complex Coronary Cases - ppt download
